SCHEMBL414391

SCHEMBL414391

[Hg+2].[O-]B([O-])Oc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 3/20 0.43
TSHR P16473 1/20 0.43
CA4 P22748 1/20 0.39
KCNA3 P22001 1/20 0.36
CA5A P35218 1/20 0.35
CA5B Q9Y2D0 1/20 0.35
CA1 P00915 2/20 0.34
CA2 P00918 2/20 0.34
NR1H2 P55055 1/20 0.33
BAX Q07812 1/20 0.33
MAOA P21397 1/20 0.33
SOS1 Q07889 1/20 0.32
LMNA P02545 1/20 0.32
GAA P10253 1/20 0.32
KMT2A Q03164 1/20 0.32
TAAR1 Q96RJ0 1/20 0.32
ALDH1A1 P00352 1/20 0.32
RECQL P46063 1/20 0.32
CA9 Q16790 1/20 0.32
SRC P12931 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lithium Ion SCHEMBL28887480 0.94 LTA4H (0.43) LTA4HTSHRCA4KCNA3CA5A
SCHEMBL187417 0.94 LTA4H (0.43) LTA4HTSHRCA4KCNA3CA5A
SCHEMBL28459811 0.94 LTA4H (0.43) LTA4HTSHRCA4KCNA3CA5A
SCHEMBL31538469 0.94 LTA4H (0.43) LTA4HTSHRCA4KCNA3CA5A
SCHEMBL29118344 0.94 LTA4H (0.43) LTA4HTSHRCA4KCNA3CA5A
SCHEMBL29232696 0.94 LTA4H (0.43) LTA4HTSHRCA4KCNA3CA5A
SCHEMBL188076 0.94 LTA4H (0.43) LTA4HTSHRCA4KCNA3CA5A
Lithium Ion SCHEMBL188290 0.94 LTA4H (0.43) LTA4HTSHRCA4KCNA3CA5A
Potassium Ion SCHEMBL187986 0.94 LTA4H (0.43) LTA4HTSHRCA4KCNA3CA5A
SCHEMBL29213652 0.94 LTA4H (0.43) LTA4HTSHRCA4KCNA3CA5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 528 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240065977-A1 MYDRIATIC AND ANTI-MUSCARINIC AGENT COMPOSITION FOR OPHTHALMIC USE SENTISS PHARMA PRIVATE LIMITED (IN) 2024-02-29 US claimed
US-20230363380-A1 INSTRINSICALLY ANTIMICROBIAL POROSIC MATRIX COMPOSITES AND METHOD OF MANUFACTURE THEREOF WILSON JOHN PAUL (US) 2023-11-16 US claimed
EP-4271361-A1 MYDRIATIC AND ANTI-MUSCARINIC AGENT COMPOSITION FOR OPHTHALMIC USE Sentiss Pharma Private Limited (IN) 2023-11-08 EP claimed
US-20230233572-A1 OPHTHALMIC COMPOSITIONS COMPRISING A COMBINATION OF FLUOROQUINOLONE ANTIBACTERIAL AGENT AND AN ANTI-INFLAMMATORY AGENT SENTISS PHARMA PRIVATE LIMITED (IN) 2023-07-27 US claimed
US-11673071-B2 Isotopic compositions BOTANICAL WATER TECHNOLOGIES IP LTD (GB) 2023-06-13 US claimed
EP-4149427-A1 OPHTHALMIC COMPOSITIONS COMPRISING A COMBINATION OF FLUOROQUINOLONE ANTIBACTERIAL AGENT AND AN ANTI-INFLAMMATORY AGENT Sentiss Pharma Private Limited (IN) 2023-03-22 EP claimed
WO-2022144798-A1 MYDRIATIC AND ANTI-MUSCARINIC AGENT COMPOSITION FOR OPHTHALMIC USE SENTISS PHARMA PRIVATE LIMITED (IN) 2022-07-07 WO claimed
US-20220079145-A1 INSTRINSICALLY ANTIMICROBIAL POROSIC MATRIX COMPOSITES AND METHOD OF MANUFACTURE THEREOF WILSON JOHN PAUL (US) 2022-03-17 US claimed
WO-2021250482-A1 OPHTHALMIC COMPOSITIONS COMPRISING A COMBINATION OF FLUOROQUINOLONE ANTIBACTERIAL AGENT AND AN ANTI-INFLAMMATORY AGENT SENTISS PHARMA PRIVATE LIMITED (IN) 2021-12-16 WO claimed
EP-2881143-B1 Hair colouring method NOXELL CORP (US) 2021-04-07 EP claimed
WO-2006085907-A2 SANITIZING COMPOSITION AND METHOD OF PREPARATION BROWN STEVEN J (US) 2006-08-17 WO claimed
US-20060025391-A1 Combination of azelastine and steroids CIPLA LIMITED (IN) 2006-02-02 US claimed
US-20050271595-A1 Sanitizing composition and method of preparation BROWN JAMES S 2005-12-08 US claimed
EP-1519731-A1 COMBINATION OF AZELASTINE AND STEROIDS Cipla Ltd. (IN) 2005-04-06 EP claimed
WO-2003105856-A1 COMBINATION OF AZELASTINE AND STEROIDS CIPLA LIMITED (IN) 2003-12-24 WO claimed
US-4829083-A 2-AMINO-2-HYDROXYMETHYL-1,3-PROPANEDIOL OR HOMOLOG DISPERSA AG (CH) 1989-05-09 US claimed
EP-0109561-B1 CELIPROLOL FOR THE TREATMENT OF GLAUCOMA RORER INTERNATIONAL (OVERSEAS) INC. (US) 1988-03-23 EP claimed
US-4470965-A Celiprolol for the treatment of glaucoma USV PHARMACEUTICAL CORPORATION (US) 1984-09-11 US claimed
EP-0109561-A1 Celiprolol for the treatment of glaucoma RORER INTERNATIONAL (OVERSEAS) INC. (US) 1984-05-30 EP claimed
US-4121940-A TITANIUM OXIDE, ZINC OXIDE, PARAFORMALDEHYDE, VITREOUS CARBON MICHEL GEORGE H 1978-10-24 US claimed